Nigella

DRUG2 trials

Sponsors

Hôpital Universitaire Sahloul

Conditions

COVID-19 Acute Respiratory Distress SyndromeSARS-CoV2 Infection

Phase 1

Nigella 5 in the Treatment of SARS COV2 (COVID-19)

CompletedNCT04914767

Hôpital Universitaire SahloulSARS-CoV2 Infection

Start: 2021-03-01End: 2021-12-31Updated: 2022-02-21

Unknown Phase

Nigelle 5 in Prevention of Influanza

CompletedNCT04989101

Hôpital Universitaire SahloulCOVID-19 Acute Respiratory Distress Syndrome

Start: 2021-06-05End: 2021-08-31Updated: 2022-01-24